Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Immunovant (Nasdaq: IMVT) will report financial results for its first quarter ended June 30, 2026 on Thursday, August 6, 2026, before the market opens.

Rhea-AI Summary

Immunovant (Nasdaq: IMVT) will report financial results for its first quarter ended June 30, 2026 on Thursday, August 6, 2026, before the market opens. Roivant Sciences (ROIV), Immunovant’s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that day, including a business update for Immunovant. Access details, webcast links, and the archived replay will be available in the “News & Events” section of Immunovant’s investor website.

Argus Jul 24 session

+0.10% close to close Open Argus

Details

News Market Reaction – IMVT

In the Jul 24 session, IMVT gained 0.10%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The scheduled first-quarter report is best assessed alongside Net Selling: platform data records 16,...

Analysis

The scheduled first-quarter report is best assessed alongside Net Selling: platform data records 16,544 shares sold and 0 bought across 10 transactions in 90 days. The August 6 results and business update are the next disclosed information point.

Key Figures

Reporting period end: June 30, 2026 Results date: August 6, 2026 Conference call time: 8:00 a.m. ET

Reporting period end

June 30, 2026

First quarter

Results date

August 6, 2026

Before the market opens

Conference call time

8:00 a.m. ET

Same day as the results announcement

Previous Earnings date Reports

2 past events · Latest: May 11

Same Type 2 events

1. May 11

   Earnings date notice

   24h Move

   -1.4%

   Fourth-quarter results and business update were scheduled for May 20, 2026.

2. Jan 23

   Earnings date notice

   24h Move

   +2.3%

   Third-quarter results and business update were scheduled for February 6, 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the market opens. Roivant Sciences Ltd. (ROIV), Immunovant’s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant.

To access the Roivant (Nasdaq: ROIV) conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “News & Events” in the Investors section of the Immunovant website at https://www.immunovant.com/investors/news-events/ir-calendar. The archived webcast will be available on Immunovant’s website after the conference call.

About Immunovant 

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. 

Contacts: 

Investors 

Keyur Parekh 

keyur.parekh@roivant.com  

Media 

Stephanie Lee 

stephanie.lee@roivant.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Immunovant (IMVT) report first-quarter 2026 financial results?

Immunovant will report first-quarter 2026 financial results on Thursday, August 6, 2026, before the market opens. According to Immunovant, the quarter covers the period ended June 30, 2026, and the release will precede a same-day business update call.

What time is the Immunovant (IMVT) and Roivant (ROIV) earnings conference call on August 6, 2026?

The Roivant-hosted conference call including Immunovant’s update is scheduled for 8:00 a.m. ET on August 6, 2026. According to Immunovant, the event will feature a business update following the financial results release earlier that morning.

Who is hosting the August 6, 2026 Immunovant (IMVT) earnings and business update call?

Roivant Sciences (Nasdaq: ROIV), Immunovant’s majority stockholder, will host the live conference call and webcast. According to Immunovant, the call on August 6, 2026 will include a specific business update related to Immunovant.

How can investors access the Immunovant (IMVT) Q1 2026 earnings conference call by phone?

Investors can access the Roivant conference call by phone by registering online through the provided registration link. According to Immunovant, registration details are available alongside webcast information in the investor “News & Events” section of its website.

Where will the Immunovant (IMVT) August 6, 2026 webcast details be posted?

Webcast and presentation details will be posted under “News & Events” in the Investors section of Immunovant’s website. According to Immunovant, this includes access information and the IR calendar entry for the August 6, 2026 event.

Will a replay of the Immunovant (IMVT) August 6, 2026 earnings call be available?

Yes, an archived webcast of the August 6, 2026 conference call will be available on Immunovant’s website. According to Immunovant, investors can access the replay in the investor section after the live call concludes.